A combination of physicochemical tropism and affinity moiety targeting of lipid nanoparticles enhances organ targeting
Marco E. ZamoraiD, Serena Omo‐LamaiiD, Manthan N. PateliD, Jichuan WuiD, Evguenia ArguiriiD, Muzykantov Vr, Jacob W. MyersoniD, Oscar Armando Marcos-ContrerasiD, Jacob Samuel BrenneriD
Abstract
Two camps have emerged in the targeting of nanoparticles to specific organs and cell types: affinity moiety targeting, which conjugates nanoparticles to antibodies or similar molecules that bind to known surface markers on cells; and physicochemical tropism, which achieves specific organ uptake based on the nanoparticles physical or chemical features (e.g., binding to endogenous proteins). Because these camps are largely non-overlapping, the two targeting approaches have not been directly compared or combined. Here we do both, using intravenous (IV) lipid nanoparticles (LNPs) whose original design goal was targeting to the lungs endothelial cells. For an affinity moiety, we utilized PECAM antibodies, and for physicochemical tropism, we used cationic lipids, both having been heavily studied for lung targeting. Surprisingly, the two methods yield nearly identical levels of lung uptake. However, aPECAM LNPs display much greater specificity for endothelial cells. Intriguingly, LNPs that possess both targeting methods had >2-fold higher lung uptake than either method alone. The combined-targeting LNPs also achieved greater uptake in already inflamed lungs, and greater uptake in alveolar epithelial cells. To understand how the macro-scale route of delivery affects organ targeting, we compared IV injection vs. intra-arterial (IA) injection into the carotid artery. We found that IA combined-targeting LNPs achieve 35% of the injected dose per gram (%ID/g) in the brain, a level superior to any other reported targeting method. Thus, combining affinity moiety targeting and physicochemical tropism provides benefits that neither targeting method achieves alone. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=56 SRC="FIGDIR/small/568061v1_ufig1.gif" ALT="Figure 1"> View larger version (18K): org.highwire.dtl.DTLVardef@281d31org.highwire.dtl.DTLVardef@1948026org.highwire.dtl.DTLVardef@693f99org.highwire.dtl.DTLVardef@1ce74cb_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 23
- FWCI
- 1.87
- Field percentile
- top 15%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
S. Omo-Lamai, M. E. Zamora, … J. S. Brenner·bioRxiv·Jul 21, 2023
- Marginated neutrophils in the lungs effectively compete for nanoparticles targeted to the endothelium, serving as a part of the reticuloendothelial system
Marco E. Zamora, Eno‐Obong Essien, … Jacob Samuel Brenner·ACS NanoPeer-reviewed·Aug 6, 2024
- Programmable Lipid Nanoparticle Targeting via Corona Engineering
Alişan Kayabölen, Cian Schmitt-Ulms, … Omar O. Abudayyeh·bioRxiv·Mar 1, 2026
- Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium
Tapas Ranjan Nayak, Adrián Chrastina, … Jan E. Schnitzer·Nature NanotechnologyPeer-reviewed·Oct 8, 2024
- Enhancing functionalized liposome avidity to cells via lipid phase separation
T. Q. Vu, L. E. Sant'Anna, N. Kamat·bioRxiv·Oct 18, 2022
- Extrahepatic, cell-specific delivery of LNPs through competitive inhibition of ApoE-mediated uptake
Joshua C. Bufton, Thomas Green, … Ben M. Carter·bioRxiv·Aug 4, 2026